Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: United Kingdom Clear all

179 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20042
20057
20069
20076
20088
20096
20104
20115
20122
20134
20147
201511
20165
20174
20186
20198
202011
20214
202213
202311
202413
202516
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Active, not recruiting43
Recruiting37
Terminated26
Unknown status7
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC19
AstraZeneca16
Hoffmann-La Roche15
Eli Lilly and Company12
Pfizer9
Bristol-Myers Squibb8
Boehringer Ingelheim7
Daiichi Sankyo6
Novartis Pharmaceuticals6
ETOP IBCSG Partners Foundation4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung179
Lung Neoplasms40
Neoplasm Metastasis10
Carcinoma9
Neoplasms8
Lung Diseases6
Adenocarcinoma4
Carcinoma, Squamous Cell4
Respiratory Tract Neoplasms4
Adenocarcinoma of Lung3

Trials

Showing 1 to 25 of 179. Each trial links to its page on Pharma Observatory.

79 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.